Position in NCNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,806
-$29,268 QoQ
Shares Held
13,433
+6550.0% QoQ
Ownership
0.323%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NCNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,794,912 across 147 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | 29,790 | $3,954,026 | |||
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in NCNA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,806 | 13,433 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $48,074 | 40,399 | Shares | Defined | 2025-02-11 | |
| 2023-12-31 | $5,988 | 20,233 | Shares | Defined | 2024-02-26 | |
| 2023-03-31 | $23,596 | 24,580 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $9,509 | 14,409 | Shares | Defined | 2023-02-15 | |
| 2022-06-30 | $11,441 | 15,782 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $77,874 | 77,952 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $69,274 | 29,107 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||